PHIBRO ANIMAL HEALTH CORP Operating Income

Quick Answer

PHIBRO ANIMAL HEALTH CORP reported Operating Income of $110.47 million for fiscal year 2025.

PHIBRO ANIMAL HEALTH CORP Operating Income — Annual History

Fiscal Year Operating Income YoY Change
2025 $110.47M +107.2%
2024 $53.31M -25.8%
2023 $71.85M -9.0%
2022 $78.99M +5.5%
2021 $74.87M +8.2%
2020 $69.19M -16.9%
2019 $83.23M -15.9%
2018 $98.93M +1.0%
2017 $97.93M +14.2%
2016 $85.74M -2.2%
2015 $87.67M +37.4%
2014 $63.79M +12.4%
2013 $56.73M +15.0%
2012 $49.33M

Quarterly Operating Income

Quarter Ending Operating Income YoY QoQ
December 31, 2025 $50.33M +97.1% -1.8%
September 30, 2025 $51.26M +189.6% +52.9%
March 31, 2025 $33.52M +68.2% +31.3%
December 31, 2024 $25.53M +62.6% +44.3%
September 30, 2024 $17.70M +2537.9% -11.2%
March 31, 2024 $19.92M +7.4% +26.9%
December 31, 2023 $15.70M -0.9% +2262.7%
September 30, 2023 -$726.0K -105.3% -103.9%
  • PHIBRO ANIMAL HEALTH CORP showed an increase of +107.2% in Operating Income compared to the prior fiscal year.
  • Over the 2012–2025 period, PHIBRO ANIMAL HEALTH CORP’s operating income has grown by 124.0% (from $49.33 million to $110.47 million).
  • The most recent figure is from PHIBRO ANIMAL HEALTH CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on August 27, 2025.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment